Connect-Home: Alzheimer's Disease and Related Dementias

Официальное название

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Обзор

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Подробное описание

Connect-Home ADRD is a Donabedian-guided intervention that introduces new structure and processes to support Skilled Nursing Facility (SNF) staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist (DCS).

The research objective is to test the efficacy of Connect-Home ADRD, a transitional care intervention, targeting Skilled Nursing Facility (SNF) patients with Alzheimer's disease and related dementias (ADRD) and their primary caregivers who discharge home and other settings of care. The study will be set in 12 North Carolina SNFs and in the patient's discharge destination (during intervention periods only). Using a cluster-randomized trial design, twelve SNFs will be randomly allocated to an intervention group (N=6 SNFs) and to a control group (N=6 SNFs) by a study statistician masked to SNF identity. 360 dyads of SNF patients with ADRD and caregivers will be enrolled in 12 SNFs.

Вмешательства

• Поведенческое Connect-Home ADRD
  Connect-Home ADRD will introduce new structure and processes to support SNF staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist.

Первичные конечные точки

• Caregiver Strain [Срок оценки: 30 days after discharge from SNF]
• Patient Neuropsychiatric Symptoms [Срок оценки: 30 days after discharge from SNF]

Вторичные конечные точки (4)

• Caregiver Depression [Срок оценки: 30 days after discharge from SNF]
• Preparedness for care transitions [Срок оценки: 30 days after discharge from SNF]
• Patient Quality of Life [Срок оценки: 30 days after discharge from SNF]
• Acute Care Use [Срок оценки: 30 days after discharge from SNF]

Критерии участия

Критерии включения

Patients:

• Ability to speak English
• Goal of discharge to home, assisted living, or long-term care
• Diagnosis of dementia
• Having a caregiver willing to participate

Caregivers:

• Ability to speak English
• Legally authorized representative (LAR) who also provides support for the person with ADRD

Inclusion criteria for SNFs:

• Location within 120 miles of UNC-Chapel Hill
• Admission of at least 75 SNF patients per year

Критерии исключения

Patients:

• Planned hospital readmission for procedures or treatments within 30 days post enrollment.

Caregivers:

• LAR is a court-appointed guardian.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Поддерживающая терапия

Центры проведения

США · 1 центр

• University of North Carolina at Chapel Hill — Chapel Hill

Идентификаторы

NCT: NCT06840587 · 24-2766 · 2R01NR017636-05A1

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗